Taysha Gene Therapies, Inc. company logo
Taysha Gene Therapies, Inc. logo

Taysha Gene Therapies, Inc. (TSHA) EBITDA

Annual EBITDA

-$85.38M$15.37M-21.96%

Summary

Current Value
As of today, TSHA annual EBITDA is -$85.38M, down -21.96% on
Historical Performance
TSHA annual EBITDA is up +50.59% over the past 3 years, and down -7557.04% over the past 5 years
All-Time High Comparison
TSHA annual EBITDA is currently -7557.04% below its historical high of -$1.12M set on
3-Year Low Comparison
TSHA annual EBITDA is +30.89% above its 3-year low of -$123.54M reached on an earlier date
Sector Comparison
TSHA annual EBITDA is higher than 19.68% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

TSHA Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA-$85.38M-22.0%+50.6%-7557.0%-7557.0%
Quarterly EBITDA-$33.74M-62.5%-34.0%-124.3%-2925.8%
TTM EBITDA-$100.98M-24.4%+34.4%-292.2%-8956.5%
Price$5.14+166.3%+155.7%-81.1%
PE Ratio-
Annual Revenue$8.33M-46.1%+100.0%+100.0%+100.0%
Annual EPS-$0.36+62.8%+92.3%-1086.0%-1086.0%
Annual EBIT-$86.62M-21.4%+50.0%-7668.7%-7668.7%
Annual Net Income-$89.30M+20.0%+48.8%-7908.8%-7908.8%

EBITDA Highs

TSHA Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y-$70.00M-22.0%
5Y-$42.99MN/A-98.6%
All-$1.12M-7557.0%

EBITDA Lows

TSHA Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$123.54MN/A+30.9%
5Y-$172.78M+50.6%
All-$172.78M+50.6%

EBITDA History

YearValueChange
-$85.38M-22.0%
-$70.00M+43.3%
-$123.54M+28.5%
YearValueChange
-$172.78M-301.9%
-$42.99M-3,755.9%
-$1.12M-

FAQ

  • What is the current annual EBITDA of TSHA?

    As of today, TSHA annual EBITDA is -$85.38M

  • What is 1-year change in TSHA annual EBITDA?

    TSHA annual EBITDA is down -21.96% year-over-year

  • What is 3-year change in TSHA annual EBITDA?

    TSHA annual EBITDA is up +50.59% over the past 3 years

  • How far is TSHA annual EBITDA from its all-time high?

    TSHA annual EBITDA is currently -7557.04% below its historical high of -$1.12M set on December 31, 2019

  • How does TSHA annual EBITDA rank versus sector peers?

    TSHA annual EBITDA is higher than 19.68% of companies in Healthcare sector

  • When is TSHA next annual earnings release?

    The next annual earnings release for TSHA is on

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. TSHA Official Website www.tayshagtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1806310/000119312525263506/0001193125-25-263506-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1806310/000095017025027348/0000950170-25-027348-index.htm
  4. TSHA Profile on Yahoo Finance finance.yahoo.com/quote/TSHA
  5. TSHA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tsha